Phase III Trial in Acute Promyelocytic Leukemia Patients
- Conditions
- Interventions
- First Posted Date
- 2007-06-05
- Last Posted Date
- 2022-10-12
- Target Recruit Count
- 276
- Registration Number
- NCT00482833
- Locations
- 🇦🇹
Universitätsklinik Innsbruck Hämatologie Onkologie, Innsbruck, Austria
🇦🇹Krankenhaus der Barmherzigen Schwestern Linz, Linz, Austria
🇦🇹Universitätsklinik für Innere Medizin III Salzburg, Salzburg, Austria
Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase
- Conditions
- First Posted Date
- 2007-06-01
- Last Posted Date
- 2022-01-18
- Target Recruit Count
- 74
- Registration Number
- NCT00481052
- Locations
- 🇮🇹
Unità Operativa Ematologica - Università degli Studi di Bari, Bari, Italy
🇮🇹Sezione di Ematologia e Trapianti Spedali Civili, Brescia, Italy
🇮🇹Ospedale Ferrarotto, Catania, Italy
"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients
- Conditions
- Interventions
- First Posted Date
- 2007-05-21
- Last Posted Date
- 2022-10-12
- Target Recruit Count
- 102
- Registration Number
- NCT00475280
- Locations
- 🇮🇹
Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli", Napoli, Italy
🇮🇹USL 8 - Ospedale S.Donato, Arezzo, Italy
🇮🇹Az. Ospedaliera S. G. Moscati, Avellino, Italy
Safety, Tolerability, and Efficacy of Deferasirox in MDS
- First Posted Date
- 2007-05-04
- Last Posted Date
- 2016-11-22
- Target Recruit Count
- 158
- Registration Number
- NCT00469560
- Locations
- 🇮🇹
SOC EMATOLOGIA ASO SS Antonio e Biagio, Alessandria, Italy
🇮🇹Clinica Ematologica - Università degli Studi, Genova, Italy
🇮🇹Clinica Ematol Università di Perugia, Policlinico Monteluce, Perugia, Italy
Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia
- Conditions
- First Posted Date
- 2007-04-27
- Last Posted Date
- 2018-08-28
- Target Recruit Count
- 57
- Registration Number
- NCT00466726
- Locations
- 🇮🇹
Ospedali Riuniti di Bergamo, Bergamo, Italy
🇮🇹Universita Degli Studi di Bari, Bari, Italy
🇮🇹USD Trapianti di midollo per adulti - Cattedra di Ematologia - Università degli Studi di Brescia, Brescia, Italy
Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia
- First Posted Date
- 2007-04-19
- Last Posted Date
- 2013-09-06
- Target Recruit Count
- 86
- Registration Number
- NCT00462332
- Locations
- 🇮🇹
ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE, Lecce, Italy
🇮🇹Ospedale Regionale A. Pugliese, Catanzaro, Italy
🇮🇹Universita di Ferrara, Ferrara, Italy
Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia
- Conditions
- First Posted Date
- 2007-04-11
- Last Posted Date
- 2019-02-15
- Target Recruit Count
- 470
- Registration Number
- NCT00458848
- Locations
- 🇮🇹
Ospedale S. Donato, Arezzo, Italy
🇮🇹S.G. Moscati Hospital, Avellino, Italy
🇮🇹Ospedale Binaghi, Cagliari, Italy
AML Treatment in Untreated Adult Patients
- Conditions
- Locations
- 🇮🇹
Dr.ssa Mastrullo, Napoli, Italy
🇮🇹Prof. D'Arco, Nocera Inferiore, Italy
🇮🇹Prof. Saglio, Orbassano, Italy
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
- Conditions
- First Posted Date
- 2007-02-26
- Last Posted Date
- 2018-08-07
- Target Recruit Count
- 62
- Registration Number
- NCT00439673
- Locations
- 🇮🇹
Ospedale Reg. A di Summa, Brindisi, Italy
🇮🇹Ospedale A. Businco, Cagliari, Italy
🇮🇹Università degli studi di Roma La Cattolica, Roma, Italy